Hyris signs a distribution agreement with GrowBIGogh

Hyris technology supports the fight against one of the world’s deadliest diseases, malaria.

Hyris fulfils its integration into Ulisse Biomed to give birth to a new international group ready to make its mark in the global biotech market.

Distribution agreement renewal with Biomol Laboratories, fostering the partnership in the field of personalised medicine

Hyris' signed a binding agreement for a reverse take-over, leading to a new integrated entity with Ulisse Biomed

Hyris' new T-cell Test is finally available to EU Countries to easily map patients' cellular immunity to SARS-CoV-2

PFS Partner Hyris Secures UK Triumph with Canadian Government 90-Minute COVID-19 Testing Megadeal

Hyris Ltd first ranking for COVID-19 research fund program by Regione Lombardia

Hyris Ltd on Immunological Reviews - Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment

Hyris COVID-19 Environmental Testing - Press Release